Alpirsbach, Germany, 17.03.2022
We are pleased to announce the appointment of Eyram Adjogatse as Director Business Development.
DS9 is further focusing on bridging the gap between licensed content and what can be found in public search engines to provide its pharma and biotech customers with strategic intelligence.
With a PhD in Drug Discovery and his experience from across the pharmaceutical lifecycle, Eyram understands the needs of pharma and biotech scientists and will be able to leverage the potential of DS9 technology for our customers.
Deep SEARCH 9 helps organisations discover new information, analyse the results and distribute the new intelligence across the corporate enterprise – enabling better and more confident decisions.